DSM sets Strategy 2018

DSM sets Strategy 2018

ID: 431754

(Thomson Reuters ONE) -


Royal DSM, a global science-based company active in health, nutrition and
materials, today presents its updated corporate strategy, "Driving Profitable
Growth" at its annual Capital Markets Day in Amsterdam (Netherlands).

Highlights of Strategy 2018

* After a period of transformation, DSM will focus on improving its financial
results through organic growth, reducing costs and strict capital allocation
* The Nutrition and Performance Materials businesses offer great potential for
growth through sustainable innovative solutions capturing opportunities the
global megatrends offer
* DSM will execute cost reduction and efficiency improvement programs, which
will result in combined savings of ?250-300 million (to be fully achieved by
the end of 2018) through the earlier announced program for the global
support functions and a new program in Nutrition; the costs of these
programs will amount to ?200-250 million
* DSM has set two targets for this three-year strategic period:

* EBITDA growth - high single-digit annual percentage increase
* Return On Capital Employed (ROCE) growth - high double-digit annual
basis points increase
* DSM is stepping-up its sustainability approach, as a business driver
throughout the value chain while reducing its own footprint further
* DSM is adjusting its organizational model and way of working to support the
delivery of its targets
* DSM will extract significant value from the Pharma and Bulk Chemicals joint
ventures in the coming years
* The targets of Strategy 2018 are based on current macro-economic conditions
and exchange rates

Feike Sijbesma, CEO and Chairman of the DSM Managing Board, commented:
"We have transformed the company successfully into a science-based company in
health, nutrition and materials. The global megatrends that drive our business




remain highly relevant. Our focus on the growth drivers High Growth Economies,
Innovation and Sustainability has created DSM's current platform for growth.

Organic growth, supported by cost reductions and strict capital allocation will
enable us to improve our financial results. This is reflected in the two targets
set for the strategic period: EBITDA and ROCE growth.

We will extract significant value from the Pharma and Bulk Chemicals joint
ventures in the coming years, providing financial headroom. We do not expect to
engage in large acquisitions in the near future as we continue to integrate
recent acquisitions, which have made a strong contribution to earnings.

Having made important steps in the strategic period behind us, DSM is now a more
global, innovative and sustainable company with a portfolio and strategy geared
at improving financial results."

Video-webcast and presentations
A conference call for the media will be held at 09.00 hrs (CET). Details on how
to access this call can be found on www.dsm.com. The DSM Capital Markets Day can
be followed live via Video webcast from 13.30-19.00 hrs (CET). The presentations
can be found on www.dsm.com as from 13.30 hrs (CET).

DSM - Bright Science. Brighter Living.(TM)
Royal DSM is a global science-based company active in health, nutrition and
materials. By connecting its unique competences in Life Sciences and Materials
Sciences DSM is driving economic prosperity, environmental progress and social
advances to create sustainable value for all stakeholders simultaneously. DSM
delivers innovative solutions that nourish, protect and improve performance in
global markets such as food and dietary supplements, personal care, feed,
medical devices, automotive, paints, electrical and electronics, life
protection, alternative energy and bio-based materials. DSM and its associated
companies deliver annual net sales of about ?10 billion with approximately
25,000 employees. The company is listed on Euronext Amsterdam. More information
can be found at www.dsm.com.

Or find us on:

For more information:
DSM Corporate Communications DSM Investor Relations
Herman Betten Dave Huizing
tel. +31 (0) 45 5782017  tel. +31 (0) 45 5782864
e-mail media.contacts(at)dsm.com e-mail investor.relations(at)dsm.com




Press release-pdf:
http://hugin.info/130663/R/1963927/716717.pdf



This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.

Source: DSM N.V. via GlobeNewswire
[HUG#1963927]




Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  MorphoSys AG Reports Results for the First Nine Months of 2015 Regulated information - Ageas reports 9 Months 2015 Results
Bereitgestellt von Benutzer: hugin
Datum: 04.11.2015 - 07:15 Uhr
Sprache: Deutsch
News-ID 431754
Anzahl Zeichen: 5298

contact information:
Town:

Heerlen



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 225 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"DSM sets Strategy 2018"
steht unter der journalistisch-redaktionellen Verantwortung von

DSM N.V. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von DSM N.V.



 

Werbung



Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z